Shire Pharmaceuticals

Overview

This $460 million project consists of a 550,000-SF expansion to the existing Lexington campus. The construction includes a manufacturing plant, HGT headquarters and refurbishing of three existing buildings.

PMA is currently providing project controls services in support of Shire Pharmaceutical’s capital program. In addition, PMA provided project controls for Shire on a $460 million, 550,000-SF expansion project. The expansion includes construction of a manufacturing plant and a human genetic therapies headquarters, as well as refurbishment of three existing buildings. PMA is responsible for tracking and analyzing the project schedule and cost during the commissioning and validation phases.

Photo Credit: WOODRUFF/BROWN of Boston Business Journal